TITLE

Acute complications

AUTHOR(S)
Peragallo-Dittko, Virginia; Robertson, Carolyn; Hurley, Mary Lou; Begany, Timothy
PUB. DATE
August 1995
SOURCE
RN;Aug95, Vol. 58 Issue 8, p36
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the treatment of the acute complications of diabetes. Signs of hypoglycemia; Risk factors for hypoglycemia; Treatment of diabetic ketoacidosis; Detection of hyperglycemic hyperosmolar nonketotic syndrome.
ACCESSION #
9509103571

 

Related Articles

  • Nature Medicine: Scientists uncover potential treatment for painful side effect of diabetes.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that a potential treatment for the side effects of diabetes has been discovered by the scientists.

  • Authors Reply. Subramanian, Usha // JGIM: Journal of General Internal Medicine;Feb2010, Vol. 25 Issue 2, p172 

    A response by Usha Subramanian to a letter to the editor about her article "Open Access Implementation and Diabetes Outcomes" in the 2009 issue of the journal is presented.

  • Diabetic Nephropathy.  // Diabetes Care;Jan2000 Supplement 1, Vol. 23, pS69 

    Provides recommendations regarding the detection and treatment of diabetic nephropathy. History of diabetic nephropathy; How to screen for albuminuria; Information on the use of antihypertensive agents.

  • Aspirin therapy in diabetes.  // Clinical Diabetes;1998, Vol. 16 Issue 2, p75 

    Focuses on the findings of investigators on the use of aspirin therapy in patients diagnosed with diabetes for treatment of cardiovascular complications. Indepth look at the evidence they found; How aspirin works when used for treatment of the complications; Detailed information on secondary...

  • Osteoporosis: An Under-appreciated Complication of Diebetes. Brown, Sue A.; Sharpless, Julie L. // Clinical Diabetes;Winter2004, Vol. 22 Issue 1, p10 

    Presents information on diabetes-related osteoporosis. Definition of osteoporosis; Annual average number of bone fractures in the U.S.; Risk factors for osteoporotic fractures in diabetes; Measures to prevent osteoporosis; Clinical considerations for therapeutic interventions; Treatment options...

  • Diabetic neuropathies. Little, Ann A.; Edwards, James L.; Feldman, Eva L. // Practical Neurology (BMJ Publishing Group);Apr2007, Vol. 7 Issue 2, p82 

    The article focuses on the common and uncommon primary neuropathies associated with diabetes. They include distal sensorimotor polyneuropathy, painful small fibre neuropathy, acute painful neuropathy, diabetic automatic neuropathy, cardiovascular autonomic neuropathy, and mononeuropathies. The...

  • Metformin may protect against intrahepatic cholangiocarcinoma in diabetes.  // Endocrine Today;Jan2013, Vol. 11 Issue 1, p18 

    The article reports on a study which found that patients with diabetes who received metformin were at reduced risk for intrahepatic cholangiocarcinoma, whereas biliary tract disease, cirrhosis, diabetes and smoking increased that risk.

  • Controlling diabetes complications naturally. LaValle, James B. // Drug Store News;11/29/99, Vol. 21 Issue 19, p26 

    Presents information on several nutritional supplements recognized for their role in controlling diabetes complications. Alpha-lipoic acid; Prostrate extract with zinc; Gymnema (gymnema sylvestre).

  • New Modes of Insulin Administration: Do They Have a Role in Clinical Diabetes?  // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p126 

    Editorial. Focuses on the treatment of diabetes mellitus. Complications of diabetes; Factors that led to the development of various modes of insulin administration; Details on the maintenance of normoglycemia; Role of insulin administration in clinical practice.

  • Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-α-D3. Stefanovic, V; Djordjevic, V; Ivic, M; Mitic-Zlatkovic, M; Vlahovic, P // Annals of Clinical Biochemistry;Jan2005, Vol. 42 Issue 1, p55 

    Background: Plasma cell differentiation antigen 1 (PC-1) is an inhibitor of insulinreceptor tyrosine-kinase. PC-1 content is elevated in muscle and adipose tissue from insulin-resistant subjects and its elevation correlates with in vivo insulin resistance. It is known that insulin resistance in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics